What are polynucleotides (PDRN) in skincare?

Polynucleotides, often labeled PDRN, are purified DNA fragments used in aesthetic medicine and skincare to support repair signaling, hydration behavior, and tissue quality. They are often derived from salmon DNA because it can be purified and is structurally compatible with human tissue.

Is “salmon DNA” the same as PDRN?

In most aesthetic contexts, “salmon DNA” refers to polynucleotides/PDRN derived from salmon sources. The headline is marketing; the functional concept is DNA fragments used to support regenerative signaling.

What does PDRN actually do for the skin?

PDRN is generally used to support skin quality by encouraging repair signaling, improving hydration patterns, and supporting the tissue environment. It is commonly discussed for concerns like thin-looking skin, under-eye crepiness, post-treatment recovery support, and overall resilience.

What is the difference between injectable PDRN and topical PDRN?

Injectable PDRN delivers polynucleotides directly into the skin, where they can influence tissue behavior more directly. Topical PDRN products act primarily at the surface and upper layers and may support hydration and soothing, but they do not replicate the depth or effect of injections.

Is PDRN better than hyaluronic acid?

They serve different roles. Hyaluronic acid primarily supports hydration and plumping by binding water, while PDRN is positioned as a signaling ingredient that supports repair behavior and tissue quality. One is not universally “better”—the choice depends on the skin’s needs and the treatment goal.

Can PDRN replace fillers?

PDRN is not a structural volumizer and does not replace fillers for contour or volume restoration. It is typically used to support skin quality and the tissue environment rather than to create lift or rebuild facial architecture.

Who benefits most from polynucleotides?

Polynucleotides are often chosen by people focused on tissue quality—skin that looks thin, stressed, or less resilient, areas like under-eye crepiness, and recovery support after procedures. They are less likely to produce dramatic changes in advanced laxity or significant volume loss.

Where is PDRN being oversold?

PDRN is sometimes marketed as a dramatic anti-aging solution or a filler replacement. In reality, it is best understood as a supportive regenerative tool that may improve skin behavior and resilience, not a substitute for structural correction or instant contour change.

“Salmon DNA” Isn’t Magic — It’s Signaling

Dr. Lazuk
Feb 15
6 min read

polynucleotides skincare, PDRN explained, salmon DNA skin treatment, PDRN injection benefits, topical PDRN serum, polynucleotide vs filler, polynucleotide vs hyaluronic acid, PDRN under eye, PDRN for acne scars, regenerative skincare ingredients, bioidentical skincare trend

“Salmon DNA” Isn’t Magic — It’s Signaling

By Dr. Lazuk, Chief Dermatologist and CEO of Lazuk Cosmetics® | Esthetics®

I cannot tell you how many times lately someone has leaned in and asked me, half curious and half skeptical:

“Dr. Lazuk… is salmon DNA really the future?”

The name alone makes it sound like either a breakthrough or a gimmick.

The truth, as usual, sits quietly in the middle.

Polynucleotides — often marketed as PDRN — are fragments of DNA. Most commonly, they’re derived from salmon because salmon DNA is structurally compatible with human tissue and can be purified safely. That compatibility is what gave the ingredient its early medical credibility.

But here’s what matters more than the fish:

These fragments act as biological messengers.

Not fillers.Not hydrators in the traditional sense.Not surface plumpers.

Messengers.

When tissue is stressed, injured, inflamed, or depleted, certain signaling pathways activate to initiate repair. PDRN works by interacting with those pathways — particularly ones involved in fibroblast activity, microcirculation, and tissue regeneration.

In simpler terms, it encourages the skin to behave as though it needs to repair.

That’s why dermatology forums are discussing it seriously. It isn’t just a cosmetic hydrator. It sits closer to regenerative medicine than traditional skincare.

Now here’s where the confusion begins.

There are injectable polynucleotides.

And there are topical products containing PDRN or “phyto-PDRN.”

These are not the same experience.

Injectable PDRN delivers signaling fragments directly into the dermal layer. It can stimulate collagen production, improve skin elasticity, and enhance tissue hydration at a deeper structural level. In some regenerative clinics, it’s used for acne scars, under-eye crepiness, and post-laser recovery.

Topical PDRN is different.

The skin barrier is selective. Large DNA fragments cannot simply pass through the intact stratum corneum. So topical versions rely on smaller derivatives or delivery systems designed to interact with upper layers of the skin. Their benefit tends to be more hydration support, soothing, and mild regenerative encouragement rather than deep remodeling.

Both have value.

But they do not produce identical outcomes.

The Instagram narrative often blurs this line intentionally.

You’ll see “salmon DNA” marketed as if it’s a miracle anti-aging serum capable of replacing structural support. That’s oversimplification. On the other hand, dismissing it as hype ignores the real regenerative signaling potential that dermatologists have studied for years.

This is what appeals to the “clean-clinical” crowd.

It feels biological. It feels intelligent. It feels like the next step beyond hyaluronic acid.

And in some ways, it is.

Hyaluronic acid holds water.PDRN influences behavior.

But influencing behavior is not the same as rebuilding architecture.

That distinction matters.

Before we go further, the real question becomes:

Where does PDRN actually fit in a longevity strategy — and when is it being oversold as a structural solution?

So now we’ve established something important.

Polynucleotides are signaling fragments.

They encourage repair behavior.

They are not volumizers.

They are not lifting devices.

They are not a substitute for structural architecture.

Now we need to separate what’s happening on Instagram from what’s happening biologically.

Let’s start with injectable PDRN.

When polynucleotides are injected into the dermis, they bypass the barrier entirely. That matters. They interact more directly with fibroblasts — the cells responsible for collagen production — and influence microcirculation and tissue hydration from within.

In practical terms, what does that mean?

Injectable PDRN is often used for:

• Under-eye crepiness• Acne scarring support• Early laxity• Post-laser recovery• Skin that looks thin or fatigued

It doesn’t “fill” hollow temples.

It doesn’t lift sagging cheeks.

It doesn’t replace bone loss.

What it does is improve tissue quality.

And tissue quality changes how everything else behaves.

Healthier tissue integrates filler better.

Healthier tissue heals from the laser more predictably.

Healthier tissue reflects light differently.

That’s the real value.

Now let’s talk about topical PDRN.

Topical formulations containing polynucleotides, phyto-derived DNA fragments, or fermented derivatives sit in a different category entirely. They may enhance hydration, calm irritation, and support barrier resilience — especially when paired with intelligent delivery systems.

But they do not penetrate deeply enough to remodel structural collagen in the way injectable versions can.

And that’s where expectations must be calibrated.

A serum labeled “salmon DNA” is not an injectable in a bottle.

It can support. It can soothe. It can signal gently.

But it cannot reconstruct.

This is where I see disappointment happen.

Someone uses a high-end PDRN serum expecting the lifting effect they saw in a clinic demo video. The two are not comparable.

And then they conclude, “It doesn’t work.”

It works — just not in the way the algorithm promised.

Now, let’s place PDRN into the regenerative stack properly.

If someone needs structural support after weight loss or age-related fat redistribution, fillers or biostimulators address architecture.

If someone needs collagen reinforcement over time, biostimulators initiate scaffold rebuilding.

If someone needs regenerative signaling to improve tissue behavior and elasticity, PDRN fits beautifully.

If someone needs growth-factor amplification, PRP may be more appropriate.

If someone needs cellular communication at a more advanced level, exosomes enter the conversation.

Each tool has a lane.

The problem happens when lanes blur.

Polynucleotides are not a replacement for fillers.

They are not a substitute for collagen biostimulation in advanced laxity.

They are not magic anti-aging DNA repair kits.

They are intelligent signaling molecules that enhance the environment in which other treatments operate.

And when used that way, they shine.

The clean-clinical crowd loves them because they feel biologically harmonious.

Something is comforting about using ingredients that mirror natural repair processes rather than forcing dramatic change.

But harmony does not mean hierarchy.

PDRN is part of a system.

Not the system.

The bigger philosophical shift happening in 2026 is this:

We are moving from “add more” to “help the skin behave better.”

Polynucleotides sit squarely in that behavioral category.

Which brings us to the next question:

When are they being oversold — and when do they truly make sense?

Now we get to the real conversation.

Because this is where hype either becomes clarity… or disappointment.

Polynucleotides are trending hard right now. Dermatology forums are discussing them seriously. Regenerative clinics are integrating them. Instagram is turning them into a miracle.

And whenever something becomes a miracle, I get cautious.

So let’s simplify this.

Who benefits most from PDRN?

First, patients with compromised tissue quality.

Not dramatic sagging.Not a deep structural collapse.Not severe volume loss.

But thin, tired, stressed skin.

The person whose under-eye area looks crepey despite filler.The person whose skin looks dull after repeated laser treatments. The person who healed from acne but feels their skin never fully regained elasticity.The patient whose barrier is fragile and reactive.

That’s where polynucleotides shine.

They improve behavior.

They encourage repair signaling.

They enhance hydration patterns at a cellular level.

They support microcirculation.

They create a healthier environment.

But here’s who they will not dramatically transform:

The patient with significant fat loss is expecting a visible lift. The patient has moderate to advanced laxity.The patient wanting contour change. The patient is hoping to replace the filler entirely.

PDRN does not build bone.

It does not replace volume.

It does not reposition ligaments.

It improves the terrain.

And improved terrain makes every other intervention more effective.

Now let’s talk about where it’s being oversold.

The phrase “DNA repair” gets thrown around loosely. True DNA repair is a complex intracellular process involving mechanisms far beyond what a cosmetic injectable or serum can directly perform. PDRN supports regenerative signaling — it does not rewrite your genetic code or reverse chronological aging.

It is a supportive regenerative tool, not a biological reset button.

Another oversell?

Calling it “better than filler.”

That’s like saying hydration is better than protein.

They serve different functions.

The clean-clinical movement loves PDRN because it feels biologically aligned. It sounds intelligent. It sounds like precision medicine.

But precision medicine requires precision expectations.

Used intelligently, polynucleotides can:

• Improve post-laser recovery• Enhance tissue resilience• Support under-eye quality•

Help reactive skin normalize• Pair beautifully with collagen stimulation

Used blindly, they can become another expensive layer in an already overloaded plan.

Here’s the philosophical layer I want you to understand.

We are entering a skin era where behavior matters more than surface tricks.

The future of aesthetics is not:

“Make it bigger.”“Make it tighter.”“Make it shinier.”

It’s: “Make it healthier.”

Polynucleotides fit that future beautifully.

But only when placed in their lane.

They are not anti-aging in the dramatic, viral sense.

They are longevity-supportive.

They are micro-architectural reinforcements.

They are environmental stabilizers.

And in the right patient — especially someone investing in lasers, PRP, collagen stimulation, or barrier rehabilitation — they elevate results quietly.

Quiet elevation is the theme of 2026.

Not shocked.

Not spectacle.

Not salmon headlines.

Just smarter sequencing.

If you’re thinking about PDRN, the question is not “Is it magic?”

It’s:

What does my skin actually need right now?

If the answer is behavioral improvement, it may be a powerful ally.

If the answer is structural reconstruction, we reach for different tools.

And that distinction is the difference between chasing trends and building longevity.

May your skin glow as brightly as your heart.

~ Dr. Lazuk

CEO & Co-Founder

Dr. Lazuk Cosmetics® | Lazuk Esthetics®

Alpharetta, GA | Johns Creek, GA | Milton, GA | Suwanee, GA

Entertainment-only medical disclaimer

This content is for educational and entertainment purposes only and is not intended as medical advice. Individual skin needs vary and should be evaluated by a licensed professional.

Explore the AI Skin Analysis